(ESAB) ESAB - Ratings and Ratios
Electrodes,Wires,Fluxes,Automated
ESAB EPS (Earnings per Share)
ESAB Revenue
Description: ESAB ESAB July 25, 2025
ESAB Corporation is a leading global supplier of welding consumables and equipment, offering a comprehensive range of products for various industries, including general industry, infrastructure, and energy. The companys product portfolio includes electrodes, wires, fluxes, and cutting consumables, as well as software and digital solutions to enhance customer productivity.
With a strong presence in multiple regions, including North America, Europe, and Asia Pacific, ESAB Corporation has established a diverse customer base across various end-markets. The companys sales strategy involves a combination of independent distributors and direct salespeople, allowing for effective market coverage.
From a financial perspective, ESAB Corporation has demonstrated a solid performance, with a Return on Equity (ROE) of 15.08%. To further evaluate the companys financial health, we can examine additional Key Performance Indicators (KPIs) such as Revenue Growth, Gross Margin, and Debt-to-Equity ratio. For instance, a high Gross Margin could indicate the companys ability to maintain pricing power, while a low Debt-to-Equity ratio may suggest a healthy capital structure.
To gain a deeper understanding of ESAB Corporations valuation, we can analyze metrics such as the Price-to-Sales (P/S) ratio and Enterprise Value-to-EBITDA (EV/EBITDA) ratio. These metrics can provide insights into the companys relative valuation compared to its industry peers. For example, a P/S ratio of 2.5x and an EV/EBITDA ratio of 15x could indicate whether the stock is undervalued or overvalued relative to its industry.
ESAB Stock Overview
| Market Cap in USD | 7,171m |
| Sub-Industry | Industrial Machinery & Supplies & Components |
| IPO / Inception | 2022-04-05 |
ESAB Stock Ratings
| Growth Rating | 45.3% |
| Fundamental | 67.8% |
| Dividend Rating | 61.1% |
| Return 12m vs S&P 500 | -21.6% |
| Analyst Rating | 3.91 of 5 |
ESAB Dividends
| Dividend Yield 12m | 0.31% |
| Yield on Cost 5y | 0.73% |
| Annual Growth 5y | 41.42% |
| Payout Consistency | 100.0% |
| Payout Ratio | 6.9% |
ESAB Growth Ratios
| Growth Correlation 3m | 46.1% |
| Growth Correlation 12m | -39.4% |
| Growth Correlation 5y | 94.4% |
| CAGR 5y | 44.63% |
| CAGR/Max DD 3y (Calmar Ratio) | 1.98 |
| CAGR/Mean DD 3y (Pain Ratio) | 6.83 |
| Sharpe Ratio 12m | -0.76 |
| Alpha | -28.14 |
| Beta | 1.195 |
| Volatility | 52.09% |
| Current Volume | 432.9k |
| Average Volume 20d | 442.6k |
| Stop Loss | 112.8 (-3.4%) |
| Signal | 0.07 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (242.8m TTM) > 0 and > 6% of Revenue (6% = 167.5m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -2.57pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 23.80% (prev 21.18%; Δ 2.62pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 290.4m > Net Income 242.8m (YES >=105%, WARN >=100%) |
| Net Debt (1.12b) to EBITDA (527.0m) ratio: 2.12 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.99 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (60.9m) change vs 12m ago -0.24% (target <= -2.0% for YES) |
| Gross Margin 37.56% (prev 37.47%; Δ 0.10pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 62.37% (prev 67.56%; Δ -5.19pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.92 (EBITDA TTM 527.0m / Interest Expense TTM 76.3m) >= 6 (WARN >= 3) |
Altman Z'' 2.17
| (A) 0.14 = (Total Current Assets 1.33b - Total Current Liabilities 669.1m) / Total Assets 4.87b |
| (B) 0.16 = Retained Earnings (Balance) 769.2m / Total Assets 4.87b |
| (C) 0.10 = EBIT TTM 451.7m / Avg Total Assets 4.48b |
| (D) 0.08 = Book Value of Equity 215.1m / Total Liabilities 2.71b |
| Total Rating: 2.17 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 67.84
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 2.87% = 1.44 |
| 3. FCF Margin 8.52% = 2.13 |
| 4. Debt/Equity 0.63 = 2.31 |
| 5. Debt/Ebitda 2.12 = -0.24 |
| 6. ROIC - WACC (= 2.87)% = 3.59 |
| 7. RoE 12.35% = 1.03 |
| 8. Rev. Trend 36.34% = 2.73 |
| 9. EPS Trend 87.21% = 4.36 |
What is the price of ESAB shares?
Over the past week, the price has changed by -2.73%, over one month by +4.64%, over three months by -12.85% and over the past year by -4.76%.
Is ESAB a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ESAB is around 129.56 USD . This means that ESAB is currently undervalued and has a potential upside of +10.91% (Margin of Safety).
Is ESAB a buy, sell or hold?
- Strong Buy: 5
- Buy: 2
- Hold: 3
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the ESAB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 141.5 | 21.1% |
| Analysts Target Price | 141.5 | 21.1% |
| ValueRay Target Price | 145.1 | 24.2% |
ESAB Fundamental Data Overview November 01, 2025
P/E Trailing = 26.4843
P/E Forward = 18.8679
P/S = 2.5682
P/B = 3.3
P/EG = 1.5603
Beta = 1.195
Revenue TTM = 2.79b USD
EBIT TTM = 451.7m USD
EBITDA TTM = 527.0m USD
Long Term Debt = 1.06b USD (from longTermDebt, last fiscal year)
Short Term Debt = 2.17m USD (from shortTermDebt, last quarter)
Debt = 1.34b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.12b USD (from netDebt column, last quarter)
Enterprise Value = 8.29b USD (7.17b + Debt 1.34b - CCE 218.2m)
Interest Coverage Ratio = 5.92 (Ebit TTM 451.7m / Interest Expense TTM 76.3m)
FCF Yield = 2.87% (FCF TTM 238.0m / Enterprise Value 8.29b)
FCF Margin = 8.52% (FCF TTM 238.0m / Revenue TTM 2.79b)
Net Margin = 8.70% (Net Income TTM 242.8m / Revenue TTM 2.79b)
Gross Margin = 37.56% ((Revenue TTM 2.79b - Cost of Revenue TTM 1.74b) / Revenue TTM)
Gross Margin QoQ = 37.00% (prev 37.18%)
Tobins Q-Ratio = 1.70 (Enterprise Value 8.29b / Total Assets 4.87b)
Interest Expense / Debt = 1.76% (Interest Expense 23.6m / Debt 1.34b)
Taxrate = 21.31% (17.7m / 83.0m)
NOPAT = 355.4m (EBIT 451.7m * (1 - 21.31%))
Current Ratio = 1.99 (Total Current Assets 1.33b / Total Current Liabilities 669.1m)
Debt / Equity = 0.63 (Debt 1.34b / totalStockholderEquity, last quarter 2.12b)
Debt / EBITDA = 2.12 (Net Debt 1.12b / EBITDA 527.0m)
Debt / FCF = 4.70 (Net Debt 1.12b / FCF TTM 238.0m)
Total Stockholder Equity = 1.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.99% (Net Income 242.8m / Total Assets 4.87b)
RoE = 12.35% (Net Income TTM 242.8m / Total Stockholder Equity 1.97b)
RoCE = 14.92% (EBIT 451.7m / Capital Employed (Equity 1.97b + L.T.Debt 1.06b))
RoIC = 11.88% (NOPAT 355.4m / Invested Capital 2.99b)
WACC = 9.00% (E(7.17b)/V(8.51b) * Re(10.42%) + D(1.34b)/V(8.51b) * Rd(1.76%) * (1-Tc(0.21)))
Discount Rate = 10.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.53%
[DCF Debug] Terminal Value 73.21% ; FCFE base≈264.6m ; Y1≈310.4m ; Y5≈471.6m
Fair Price DCF = 89.72 (DCF Value 5.45b / Shares Outstanding 60.7m; 5y FCF grow 18.42% → 3.0% )
EPS Correlation: 87.21 | EPS CAGR: 8.68% | SUE: 1.67 | # QB: 1
Revenue Correlation: 36.34 | Revenue CAGR: 3.39% | SUE: 1.24 | # QB: 1
Additional Sources for ESAB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle